萝莉社

(904) 244-0411 Education Research Community

Treats Adults

Luis G Ortega Paz, MD

Cardiologist

Additional languages:: Spanish

(904) 383-1011

Request appointment online

Research at a glance

Research activity

59 publications

65 citations

Why is this important?

Active clinical trials

Switching from Clopidogrel to Low-dose Prasugrel in Patients at Dual-risk Following Percutaneous Coronary Intervention: TAILOR-BLEED-2 study

Investigators: Dominick J Angiolillo, Luis G Ortega Paz
Status: Accepting Candidates
Ages: 18 Years - 99 Years
Sexes: All

The Bridging Antiplatelet Therapy with Cangrelor 2 (BRIDGE 2) Study: A Pilot Prospective Cohort, Pharmacodynamic Study of Tailored Cangrelor Bridging Dosing Regimens

Investigators: Dominick J Angiolillo, Luis G Ortega Paz
Status: Accepting Candidates
Ages: 18 Years - 99 Years
Sexes: All

My publications

59 publications

2023

Switching From Cangrelor to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention

JACC: Cardiovascular Interventions

2023

Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study

Thrombosis and Haemostasis

2023

Sex Differences in 10-Year Outcomes After Percutaneous Coronary Intervention With Drug-Eluting Stents: Insights From the DECADE Cooperation

Circulation

2022

Impact of Diabetes on 10鈥怸ear Outcomes Following ST鈥怱egment鈥揈levation Myocardial Infarction: Insights From the EXAMINATION鈥怑XTEND Trial

Journal of the American Heart Association

2022

Oral P2Y12 inhibiting therapy in patients with acute coronary syndrome: finding the sweet spot

European Heart Journal